---
title: Flamma vs SEQENS
slug_a: flammagroup
slug_b: seqens
site: cdmo
review_signal_gate: closed
canonical_path: /compare/flammagroup/seqens
generated_by: BioBM Editorial AI
---

# Flamma vs SEQENS

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Flamma (flammagroup) is listed for cdmo. Privately held small molecule CDMO with FDA-inspected cGMP facilities in Italy, USA, and China, offering custom manufacturing, development, and specialized technologies including HPAPI, continuous flow, and cryogenic API synthesis from early-stage to commercial scale.

Services: 9. Modalities: 1. Indications: 0. Locations: 7. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (9).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

SEQENS (seqens) is listed for cdmo. Global CDMO and specialty ingredients manufacturer with 16 production sites and 9 R&D centres offering custom development and GMP manufacturing of pharmaceutical APIs, intermediates, and specialty chemicals from preclinical to commercial scale.

Services: 8. Modalities: 1. Indications: 0. Locations: 15. Certifications: 9. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in locations (15).

Review summary: Review summary withheld until site-level review gate opens.